- Supported exchanges /
- NASDAQ /
- RVLPQ.NASDAQ
RVL Pharmaceuticals plc (RVLPQ NASDAQ) stock market data APIs
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
RVL Pharmaceuticals plc Financial Data Overview
| 0.0001 | |
| 0.0001 | |
| - | |
| 0.0001 | |
| 0.0001 | |
| 0-0.19 | |
| 11 141 | |
| 111 M | |
| 36 919 K | |
| 22.11 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
RVL Pharmaceuticals plc Fundamental Data is available in our Financial Data APIs
- Net Revenue 36 919 K
- EBITDA -39 390 000
- Earnings Per Share -0.71
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get RVL Pharmaceuticals plc Earnings via APIs
- Latest Release 2024-09-19
- EPS/Forecast NaN
Get RVL Pharmaceuticals plc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
